Bioactive Virus-Mimicking Nanovesicles From Dendrimersomes: A Novel Approach to Understanding SARS-CoV-2 Host-Interactions to Better Design Therapeutics

Bioactive Virus-Mimicking Nanovesicles From Dendrimersomes: A Novel Approach to Understanding SARS-CoV-2 Host-Interactions to Better Design Therapeutics

Bibliographic Details
Main Author:	Bilal Javed
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-08-01
Series:	Frontiers in Molecular Biosciences
Subjects:	COVID-19 dendrimers immune response pseudoviruses surface modifications therapeutic carriers
Online Access:	https://www.frontiersin.org/article/10.3389/fmolb.2020.00188/full

Similar Items

Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug
by: Sylwia Michlewska, et al.
Published: (2019-08-01)

Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development
by: Sheng-Wen Huang, et al.
Published: (2020-08-01)

Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2
by: Jie Hu, et al.
Published: (2020-12-01)

Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2
by: Davide Gentile, et al.
Published: (2024-02-01)

A surrogate assay for measuring Coxsackievirus A6 neutralizing antibodies
by: Yao Su, et al.
Published: (2018-12-01)

A Novel and Secure Pseudovirus Reporter System Based Assay for Neutralizing and Enhancing Antibody Assay Against Marburg Virus
by: Jinhao Bi, et al.
Published: (2022-06-01)

Silver nanoparticles with excellent biocompatibility block pseudotyped SARS-CoV-2 in the presence of lung surfactant
by: Govind Gupta, et al.
Published: (2022-12-01)

SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
by: Jeroen Pollet, et al.
Published: (2021-08-01)

A novel pseudovirus‐based mouse model of SARS-CoV-2 infection to test COVID-19 interventions
by: Ssu-Hsueh Tseng, et al.
Published: (2021-04-01)

Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
by: Qizhong Lu, et al.
Published: (2021-01-01)

Editorial: Nanomedicine in Infectious Diseases: Drug Delivery and Vaccines
by: Srujan Marepally, et al.
Published: (2022-08-01)

Development of a Bioluminescent Imaging Mouse Model for SARS-CoV-2 Infection Based on a Pseudovirus System
by: Xi Wu, et al.
Published: (2023-06-01)

Dendritic Nanotheranostic for the Delivery of Infliximab: A Potential Carrier in Rheumatoid Arthritis Therapy
by: Tamara Rodríguez-Prieto, et al.
Published: (2020-11-01)

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
by: Gaetano Donofrio, et al.
Published: (2021-04-01)

COVID-19: S-Peptide RBD <sub>484–508</sub> Induces IFN-γ T-Cell Response in Naïve-to-Infection and Unvaccinated Subjects with Close Contact with SARS-CoV-2-Positive Patients
by: Michela Murdocca, et al.
Published: (2023-06-01)

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
by: Jianhui Nie, et al.
Published: (2020-01-01)

Design and Development of a Pseudotyped-lentivirus for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
by: Hadi Hassannia, et al.
Published: (2023-11-01)

Infection of Brain Organoids and 2D Cortical Neurons with SARS-CoV-2 Pseudovirus
by: Sang Ah Yi, et al.
Published: (2020-09-01)

Comprehensive and systemic optimization for improving the yield of SARS-CoV-2 spike pseudotyped virus
by: Xinping Fu, et al.
Published: (2021-03-01)

Development of a SARS‐CoV‐2 neutralization assay based on a pseudotyped virus using a HIV system
by: Ziteng Liang, et al.
Published: (2024-04-01)

Development of a Cell-Based SARS-CoV-2 Pseudovirus Neutralization Assay Using Imaging and Flow Cytometry Analysis
by: Jerilyn R. Izac, et al.
Published: (2023-08-01)

Production and characterization of lentivirus vector-based SARS-CoV-2 pseudoviruses with dual reporters: Evaluation of anti-SARS-CoV-2 viral effect of Korean Red Ginseng
by: Jeonghui Moon, et al.
Published: (2023-01-01)

Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
by: Hancong Sun, et al.
Published: (2022-06-01)

Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants
by: Armi M. Chaudhari, et al.
Published: (2022-01-01)

The complex of PAMAM-OH dendrimer with Angiotensin (1–7) prevented the disuse-induced skeletal muscle atrophy in mice
by: Márquez-Miranda V, et al.
Published: (2017-03-01)

Small Structural Proteins E and M Render the SARS-CoV-2 Pseudovirus More Infectious and Reveal the Phenotype of Natural Viral Variants
by: Hsin-I Wang, et al.
Published: (2021-08-01)

Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles
by: Sheng Wang, et al.
Published: (2022-02-01)

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector
by: Ziteng Liang, et al.
Published: (2023-12-01)

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
by: Jose Manuel Condor Capcha, et al.
Published: (2021-01-01)

Dendrimer chemistry : concepts, syntheses, properties, applications /
by: Vogtle, F. (Fritz), 1939-, et al.
Published: (2009)

Synthesis, characterization and evaluation of pamam dendrimer-gold complex as an anion recognition material [electronic resource] /
by: Muhammad Nor Fazli Abd. Malek, 1986-, et al.
Published: (2009)

Synthesis, characterization and evaluation of pamam dendrimer-gold complex as an anion recognition material /
by: Muhammad Nor Fazli Abd. Malek, 1986-, et al.
Published: (2009)

An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding
by: Ka Man Yip, et al.
Published: (2022-07-01)

SARS-CoV-2 Prevalence and Variant Surveillance among Cats in Pittsburgh, Pennsylvania, USA
by: Santhamani Ramasamy, et al.
Published: (2023-06-01)

Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro
by: Hua-Long Xiong, et al.
Published: (2021-02-01)

Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
by: Canhao Wu, et al.
Published: (2022-03-01)

The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients
by: Dalziza Victalina de Almeida, et al.
Published: (2023-12-01)

Dendrimers as Modifiers of Inorganic Nanoparticles for Therapeutic Delivery in Cancer
by: Mkhuseli Zenze, et al.
Published: (2023-01-01)

Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins
by: Nadezhda Knauer, et al.
Published: (2019-02-01)

Dendritic macromolecules as nano-scale drug carriers: Phase solubility, in vitro drug release, hemolysis and cytotoxicity study
by: Pravinkumar M. Patel, et al.
Published: (2015-07-01)